New prognostic factor influencing long-term survival of patients with advanced gallbladder carcinoma. 2010

Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
Department of Surgery, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan. f-miura@med.teikyo-u.ac.jp

BACKGROUND Although the safety of operations has generally improved in recent years, the mortality of extended operations for advanced gallbladder carcinoma (GBC) remains high, and the outcomes of patients with advanced GBC requiring major surgery are poor. In this study, a newly formulated original stage classification of advanced GBC was evaluated to clarify prognostic factors affecting long-term survival. METHODS A total of 149 patients with resected GBC infiltrating beyond the propria muscle layer were analyzed retrospectively. These patients were classified into F0 (n = 50), F1 (n = 38), F2 (n = 38), and F3 (n = 23) according to the number of positive histopathologic factors, consisting of direct invasion to the liver, invasion to the hepatoduodenal ligament, and lymph node metastasis. Overall survival rates were compared with the Union Internationale Contre le Cancer TNM classification (6th edition). RESULTS Overall 5-year survival rates of patients with F0, F1, F2, and F3 were 60%, 35%, 5%, and 0%, respectively. Significant differences were observed, except between F2 and F3. In 38 patients with F1, there were no significant differences between 13 patients with direct invasion to the liver, 4 patients with invasion to the hepatoduodenal ligament, and 21 patients with lymph node metastasis. Multivariate analysis revealed that F classification was the most important independent risk factor to predict survival. CONCLUSIONS Patients with advanced GBC are expected to survive long if only 1 of hepatic invasion, hepatoduodenal ligament invasion, or lymph node metastasis is positive.

UI MeSH Term Description Entries
D008022 Ligaments Shiny, flexible bands of fibrous tissue connecting together articular extremities of bones. They are pliant, tough, and inextensile. Interosseal Ligament,Interosseous Ligament,Interosseal Ligaments,Interosseous Ligaments,Ligament,Ligament, Interosseal,Ligament, Interosseous
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002763 Cholecystectomy Surgical removal of the GALLBLADDER. Cholecystectomies

Related Publications

Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
May 2012, Korean journal of hepato-biliary-pancreatic surgery,
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
January 2009, Digestion,
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
October 1963, Surgery, gynecology & obstetrics,
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
January 2005, Journal of hepato-biliary-pancreatic surgery,
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
March 2024, Cancer reports (Hoboken, N.J.),
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
November 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
January 2013, International journal of surgery case reports,
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
February 2023, Oncology letters,
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
November 1997, Cancer,
Fumihiko Miura, and Takehide Asano, and Hodaka Amano, and Naoyuki Toyota, and Keita Wada, and Kenichiro Kato, and Tadahiro Takada, and Hiroshi Takami, and Gaku Ohira, and Hisahiro Matsubara
June 2006, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Copied contents to your clipboard!